Altria Group, Inc. (MO) Outlook Bolstered by New FDA Rule Proposals Targeting Foreign Tobacco Manufacturers

Altria Group, Inc. (NYSE:MO) is one of the best dividend stocks to invest in, according to Jim Simons’ Renaissance Technologies. On June 26, Altria Group, Inc. (NYSE:MO) received a significant boost after the US Food and Drug Administration issued a proposal requiring foreign tobacco manufacturers to register their establishments and list the products they sell in the country.

Copyright: katechris / 123RF Stock Photo

The new rule, if approved, will close a regulatory gap that exempted foreign entities from registration and product listing requirements. Consequently, foreign domestic manufacturers will be at par with domestic manufacturers, while also making it easier to identify illegal foreign tobacco products.

Foreign tobacco manufacturers are also required to maintain records of product labeling, advertising, and consumer information as part of the proposed regulation. The FDA proposal is part of an effort to strengthen the agency’s ability to identify illegal foreign tobacco products. Additionally, the rule would lessen competition for Altria Group, especially from illegal foreign products that have proliferated in the market.

Altria Group is one of the top dividend stocks in the Renaissance Technology portfolio with a yield of 5.83%.

Altria Group, Inc. (NYSE:MO) is a leading Fortune 500 parent company that owns major U.S. tobacco, cigar, and smoke-free product subsidiaries. Primarily, the company manufactures and sells tobacco and nicotine products under iconic brands such as Marlboro, Black & Mild, Copenhagen, Skoal, and on!

READ NEXT: 10 Best Stocks to Buy According to David Greenspan’s Slate Path Capital and 10 AI Stocks on Wall Street’s Radar: Datadog, Microsoft, and More.

Disclosure: None. Follow Insider Monkey on Google News.